Cannabinoid agonist rescues learning and memory after a traumatic brain injury

Annals of Clinical and Translational Neurology

Volumn 2, Issue 3, 2015, Pages 289-294

  Arain, Marium ^a   Khan, Maida ^a   Craig, Laura ^b   Nakanishi, Stan T ^a,c  

^a ALBERTA CHILDREN S HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF HAWAII AT HILO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID 1 RECEPTOR; DIMETHYL SULFOXIDE; DRUG VEHICLE; ISOFLURANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL TEST PARAMETERS; CRANIOTOMY; ELEVATED PLUS MAZE TEST; HISTOLOGY; LEARNING; MEMORY; MORRIS WATER MAZE TEST; NONHUMAN; RAT; RECOGNITION INDEX; TRAUMATIC BRAIN INJURY;

EID: 84961652856     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.163     Document Type: Article

References (25)

1. Prevention CfDCa. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002–2006. US Department of Health and Human Services, 2010. Available at: www.cdc.gov/TraumaticBrainInjury (accessed July 2014).
2. Moore AD, Stambrook M. Cognitive moderators of outcome following traumatic brain injury: a conceptual model and implications for rehabilitation. Brain Inj 1995;9:109–130.
3. Dikmen SS, Corrigan JD, Levin HS, et al. Cognitive outcome following traumatic brain injury. J Head Trauma Rehabil 2009;24:430–438.
4. Piomelli D. The endocannabinoid system: a drug discovery perspective. Curr Opin Investig Drugs 2005;6:672–679.
5. Breivogel CS, Sim-Selley LJ. Basic neuroanatomy and neuropharmacology of cannabinoids. Int Rev Psychiatry 2009;21:113–121.
6. Zoppi S, Perez Nievas BG, Madrigal JL, et al. Regulatory role of cannabinoid receptor 1 in stress-induced excitotoxicity and neuroinflammation. Neuropsychopharmacology 2011;36:805–818.
7. Walter L, Stella N. Cannabinoids and neuroinflammation. Br J Pharmacol 2004;141:775–785.
8. Benard G, Massa F, Puente N, et al. Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat Neurosci 2012;15:558–564.
9. Mechoulam R, Panikashvili D, Shohami E. Cannabinoids and brain injury: therapeutic implications. Trends Mol Med 2002;8:58–61.
10. Panikashvili D, Shein NA, Mechoulam R, et al. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 2006;22:257–264.
11. Panikashvili D, Simeonidou C, Ben-Shabat S, et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 2001;413:527–531.
12. Sullivan PG, Keller JN, Mattson MP, Scheff SW. Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function. J Neurotrauma 1998;15:789–798.
13. Blokland A, Ten Oever S, van Gorp D, et al. The use of a test battery assessing affective behavior in rats: order effects. Behav Brain Res 2012;228:16–21.
14. Akkerman S, Blokland A, Reneerkens O, et al. Object recognition testing: methodological considerations on exploration and discrimination measures. Behav Brain Res 2012;232:335–347.
15. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984;11:47–60.
16. Whimbey AE, Denenberg VH. Two independent behavioral dimensions in open-field performance. J Comp Physiol Psychol 1967;63:500–504.
17. Walf AA, Frye CA. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2007;2:322–328.
18. Tran LD, Lifshitz J, Witgen BM, et al. Response of the contralateral hippocampus to lateral fluid percussion brain injury. J Neurotrauma 2006;23:1330–1342.
19. White TE, Ford GD, Surles-Zeigler MC, et al. Gene expression patterns following unilateral traumatic brain injury reveals a local pro-inflammatory and remote anti-inflammatory response. BMC Genom 2013;14:282.
20. Axelson HW, Winkler T, Flygt J, et al. Plasticity of the contralateral motor cortex following focal traumatic brain injury in the rat. Restor Neurol Neurosci 2013;31:73–85.
21. Lopez-Rodriguez AB, Siopi E, Finn DP, et al. CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice. Cereb Cortex 2013 Epub 2013 Aug 19; Cereb Cortex 2015;25:35–45.
22. Vera G, Cabezos PA, Martin MI, Abalo R. Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy. Pharmacol Biochem Behav 2013;105:205–212.
23. Mathison R, Ho W, Pittman QJ, et al. Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats. Br J Pharmacol 2004;142:1247–1254.
24. Rudenko V, Rafiuddin A, Leheste JR, Friedman LK. Inverse relationship of cannabimimetic (R+)WIN 55, 212 on behavior and seizure threshold during the juvenile period. Pharmacol Biochem Behav 2012;100:474–484.
25. Blair RE, Deshpande LS, Sombati S, et al. Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy. Neuropharmacology 2009;57:208–218.